Predicting memory changes from brain radiation
Part of Brain & nervous system, Cancer clinical trials.
This study looks for biomarkers in your blood that might predict how radiation treatment affects brain function. The goal is to understand and possibly reduce cognitive side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 39 years old.
- You have a primary brain tumor confirmed by biopsy.
- You are scheduled to receive radiation therapy intended to cure or control the tumor.
- You can complete tests that measure thinking and memory.
- You are expected to live more than one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with a primary brain tumor to understand how thinking skills and brain images change over time during radiation therapy. It may help researchers measure treatment effects and better track brain changes.
This trial studies how radiotherapy affects memory and thinking in adults with certain brain or skull-base tumors. It may help doctors understand who is most likely to have thinking changes and how to monitor or support patients.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study looks at how radiation from brain tumor treatment affects memory, attention, and thinking skills in children. It uses brain scans and tests to understand these effects.
This trial studies how radiation therapy affects thinking and memory in adults with certain brain tumors. It may help doctors understand which patients are more likely to have cognitive side effects and how to measure them over time.
This study uses MRI scans to look at how radiation treatment for newly diagnosed brain metastases affects thinking and memory. It aims to understand the effects better, which may help guide future treatment.
Hear when a new Medulloblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.